Detalles de la búsqueda
1.
Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis.
Cancer Cell Int
; 22(1): 363, 2022 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402980
2.
Association of ß-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.
Eur Heart J
; 41(46): 4415-4422, 2020 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33211823
3.
Increasing the prescription rate of ß-blockers is beneficial for patients with chronic obstructive pulmonary and cardiovascular disease.
Eur Heart J
; 42(34): 3409, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948636
4.
Increase use of ß-blockers in patients with chronic obstructive pulmonary and cardiovascular disease.
Eur Heart J
; 42(12): 1181, 2021 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-33517398
5.
Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review.
Front Pharmacol
; 12: 697330, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34776941
6.
Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Ther Adv Chronic Dis
; 12: 20406223211028768, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34285789
7.
Effect of alectinib versus crizotinib on progression-free survival, central nervous system efficacy and adverse events in ALK-positive non-small cell lung cancer: a systematic review and meta-analysis.
Ann Palliat Med
; 9(4): 1782-1796, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32527124
8.
The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis.
Ther Adv Med Oncol
; 11: 1758835919855235, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217825
Resultados
1 -
8
de 8
1
Próxima >
>>